Mentice, the world’s leading endovascular simulation solution
provider, has announced the release of a new simulation training
software for transarterial chemoembolization (TACE). The new software
will be showcased at the 2017 Cardiovascular and Interventional
Radiological Society of Europe (CIRSE) congress to be held September
16-20 in Copenhagen, Denmark.

TACE is an effective, widely performed therapy performed by
interventional radiologists (IRs). It is a minimally invasive procedure
for liver cancer that delivers chemotherapy drugs and embolization
agents with great accuracy, minimizing side effects for patients. It is
however a challenging procedure that involves various sub-techniques,
complex anatomies and variant vasculatures requiring the extensive use
of radiation. Success of the procedure and impact on cost is tied to the
ability to complete it safely and accurately within the permitted
radiation doses.

“Conventional apprentice-based training in the clinical practice is
costly, resource-intensive and can have an impact on patient safety,”
comments Mentice CEO Göran Malmberg. “Our TACE software provides a safe,
effective, repeatable and highly realistic solution—allowing IRs to have
hands-on training outside of the cath lab.”

The Mentice TACE training solution is based on real-life cases,
providing the realism essential for successful training and features an
integrated radiation safety module, that provides dose monitoring for
patient and staff at all times. The software also features output of
metrics, enabling objective assessment of trainees’ progress. “Realistic
high-fidelity simulation solutions are very effective for procedures
such as TACE,” adds Malmberg. “Trainees can acquire the multi-level
skills required to perform the procedure in a dose-dependent,
time-effective way, reducing overall costs, while maintaining patient
safety.”

Attendees at CIRSE can test the new Mentice TACE training software at
the company’s booth (booth RPP1 at the Radiation Protection Pavilion).
The software will also be available for testing and demonstrations at
‘The Basics of Chemoembolization for the Liver’ session being held as
part of the ‘Principles to Practice: Education and Simulation Skills
Training’ program.

Mentice is the world leader in virtual reality-based interventional
medical simulation solutions. Our solutions help healthcare
professionals with skills acquisition, continuous development and
preprocedural planning—leading to improved productivity and outcomes.
Mentice solutions are scientifically validated, and have been
specifically developed for healthcare providers and the medical
industry. Neurovascular, cardiovascular and peripheral interventions are
just some of the areas covered by our systems. Learn more about the
features and benefits of Mentice solutions at: www.mentice.com.